Literature DB >> 18425922

Psychotherapy for depression among incurable cancer patients.

T Akechi1, T Okuyama, J Onishi, T Morita, T A Furukawa.   

Abstract

BACKGROUND: The most common psychiatric diagnosis among cancer patients is depression; this diagnosis is even more common among patients with advanced cancer. Psychotherapy is a patient-preferred and promising strategy for treating depression among cancer patients. Several systematic reviews have investigated the effectiveness of psychological treatment for depression among cancer patients. However, the findings are conflicting, and no review has focused on depression among patients with incurable cancer.
OBJECTIVES: To investigate the effects of psychotherapy for treating depression among patients with advanced cancer by conducting a systematic review of randomized controlled trials (RCTs). SEARCH STRATEGY: We searched the Cochrane Pain, Palliative and Supportive Care Group Register, The Cochrane Controlled Trials Register, MEDLINE, EMBASE, CINAHL, and PsycINFO databases in September 2005. SELECTION CRITERIA: All relevant RCTs comparing any kind of psychotherapy with conventional treatment for adult patients with advanced cancer were eligible for inclusion. Two independent review authors identified relevant studies. DATA COLLECTION AND ANALYSIS: Two review authors independently extracted data from the original reports using standardized data extraction forms. Two independent review authors also assessed the methodological quality of the selected studies according to the recommendations of a previous systematic review of psychological therapies for cancer patients that utilized ten internal validity indicators. The primary outcome was the standardized mean difference (SMD) of change between the baseline and immediate post-treatment scores. MAIN
RESULTS: We identified a total of ten RCTs (total of 780 participants); data from six studies were used for meta-analyses (292 patients in the psychotherapy arm and 225 patients in the control arm). Among these six studies, four studies used supportive psychotherapy, one adopted cognitive behavioural therapy, and one adopted problem-solving therapy. When compared with treatment as usual, psychotherapy was associated with a significant decrease in depression score (SMD = -0.44, 95% confidence interval [CI] = -0.08 to -0.80). None of the studies focused on patients with clinically diagnosed depression. AUTHORS'
CONCLUSIONS: Evidence from RCTs of moderate quality suggest that psychotherapy is useful for treating depressive states in advanced cancer patients. However, no evidence supports the effectiveness of psychotherapy for patients with clinically diagnosed depression.

Entities:  

Mesh:

Year:  2008        PMID: 18425922      PMCID: PMC6464138          DOI: 10.1002/14651858.CD005537.pub2

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  40 in total

Review 1.  [Antidepressants for treatment of depression in palliative patients : a systematic literature review].

Authors:  M Ujeyl; B Müller-Oerlinghausen
Journal:  Schmerz       Date:  2012-09       Impact factor: 1.107

Review 2.  Quantifying psychological distress among cancer patients in interventions and scales: a systematic review.

Authors:  Mei-Ling Yeh; Yu-Chu Chung; Man-Ying F Hsu; Chin-Che Hsu
Journal:  Curr Pain Headache Rep       Date:  2014-03

3.  Expert opinion on detecting and treating depression in palliative care: A Delphi study.

Authors:  Lauren Rayner; Annabel Price; Matthew Hotopf; Irene J Higginson
Journal:  BMC Palliat Care       Date:  2011-05-27       Impact factor: 3.234

4.  Prevalence of unmet needs and correlated factors in advanced-stage cancer patients receiving rehabilitation.

Authors:  Takaaki Hasegawa; Naoya Goto; Naoto Matsumoto; Yusuke Sasaki; Takashi Ishiguro; Nanori Kuzuya; Yasuyuki Sugiyama
Journal:  Support Care Cancer       Date:  2016-06-25       Impact factor: 3.603

5.  Depression and survival in metastatic non-small-cell lung cancer: effects of early palliative care.

Authors:  William F Pirl; Joseph A Greer; Lara Traeger; Vicki Jackson; Inga T Lennes; Emily R Gallagher; Pedro Perez-Cruz; Rebecca S Heist; Jennifer S Temel
Journal:  J Clin Oncol       Date:  2012-03-19       Impact factor: 44.544

6.  [Dyspnea, itching and depression in palliative medicine].

Authors:  M Mücke; R Conrad; M Bleckwenn; H Cuhls; L Radbruch; R Rolke
Journal:  Schmerz       Date:  2016-04       Impact factor: 1.107

Review 7.  Pharmacological management of depression in patients with cancer: practical considerations.

Authors:  Riccardo G V Torta; Valentina Ieraci
Journal:  Drugs       Date:  2013-07       Impact factor: 9.546

8.  The Socio-Demographic and Clinical Factors Associated with Quality of Life among Patients with Haematological Cancer in a Large Government Hospital in Malaysia.

Authors:  Das Priscilla; Awang Hamidin; Md Zain Azhar; Kon Noorjan; Md Said Salmiah; Khalid Bahariah
Journal:  Malays J Med Sci       Date:  2011-07

9.  Living with metastatic breast cancer: a qualitative analysis of physical, psychological, and social sequelae.

Authors:  Catherine E Mosher; Courtney Johnson; Maura Dickler; Larry Norton; Mary Jane Massie; Katherine DuHamel
Journal:  Breast J       Date:  2013-03-26       Impact factor: 2.431

Review 10.  Clinical Factors as a Component of the Personalized Treatment Approach to Advanced Pancreatic Cancer: a Systematic Literature Review.

Authors:  William Paul Skelton; Hiral Parekh; Jason S Starr; Jose Trevino; Jessica Cioffi; Steven Hughes; Thomas J George
Journal:  J Gastrointest Cancer       Date:  2018-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.